Considering the widespread use of the cell line, these findings could have significant implications for the research community.
The microarray facilitates drug screening in cancer stem cells and other rare cell populations.
A team of scientists at the Broad Institute has developed a new cell microarray and validated it as a potential functional genomics tool by using it to screen cells for drug resistance in melanoma.
By Justin Petrone
The National Institutes of Health has awarded $1.5 million to a team of researchers at Arizona State University to develop a high-throughput, live cell array for metabolic studies.
Led by scientists at McGill University in Montreal, the team designed a way to measure transcriptional changes in real time in single mammalian cells, and claims the approach could be used to study cell proliferation, differentiation, and apoptosis.
The Italian biochip firm has established an office in San Diego from which it aims to target the US market and eventually steer its DEPArray cell analysis platform into the clinic.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.
DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.
In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.
A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.